| Primary |
| Blood Cholesterol Increased |
36.8% |
| Hypertension |
14.0% |
| Hypercholesterolaemia |
9.6% |
| Hyperlipidaemia |
5.3% |
| Diabetes Mellitus |
5.2% |
| Blood Cholesterol |
4.5% |
| Cardiac Disorder |
3.3% |
| Blood Cholesterol Abnormal |
2.9% |
| Dyslipidaemia |
2.5% |
| Ill-defined Disorder |
2.1% |
| Myocardial Infarction |
1.7% |
| Prophylaxis |
1.6% |
| Low Density Lipoprotein Increased |
1.5% |
| Depression |
1.4% |
| Gastrooesophageal Reflux Disease |
1.4% |
| Blood Triglycerides Increased |
1.4% |
| Thyroid Disorder |
1.2% |
| Pain |
1.2% |
| Blood Pressure Abnormal |
1.2% |
| Hypothyroidism |
1.1% |
|
| Myalgia |
18.2% |
| Death |
16.1% |
| Pain In Extremity |
9.4% |
| Myocardial Infarction |
6.0% |
| Muscle Spasms |
5.5% |
| Pain |
4.5% |
| Rhabdomyolysis |
4.1% |
| Weight Decreased |
4.0% |
| Cerebrovascular Accident |
3.5% |
| Muscular Weakness |
3.2% |
| Amnesia |
2.9% |
| Drug Hypersensitivity |
2.8% |
| Weight Increased |
2.8% |
| Wrong Technique In Drug Usage Process |
2.8% |
| Malaise |
2.5% |
| No Adverse Event |
2.5% |
| Neuropathy Peripheral |
2.4% |
| Blood Cholesterol Increased |
2.4% |
| Drug Ineffective |
2.3% |
| Rash |
2.2% |
|
| Secondary |
| Blood Cholesterol Increased |
22.8% |
| Hypertension |
14.9% |
| Product Used For Unknown Indication |
11.1% |
| Drug Use For Unknown Indication |
6.7% |
| Diabetes Mellitus |
6.0% |
| Hypercholesterolaemia |
5.2% |
| Hyperlipidaemia |
4.8% |
| Cardiac Disorder |
3.4% |
| Depression |
3.3% |
| Blood Cholesterol |
2.6% |
| Blood Cholesterol Abnormal |
2.5% |
| Myocardial Infarction |
2.5% |
| Prophylaxis |
2.4% |
| Anxiety |
2.1% |
| Blood Triglycerides Increased |
2.1% |
| Low Density Lipoprotein Increased |
2.0% |
| Pain |
1.6% |
| Cardiovascular Event Prophylaxis |
1.5% |
| Gastrooesophageal Reflux Disease |
1.3% |
| Dyslipidaemia |
1.2% |
|
| Myalgia |
13.6% |
| Weight Decreased |
8.8% |
| Pain In Extremity |
8.6% |
| Weight Increased |
6.6% |
| Type 2 Diabetes Mellitus |
6.3% |
| Myocardial Infarction |
5.9% |
| Death |
5.8% |
| Muscle Spasms |
5.8% |
| Pain |
4.9% |
| Rhabdomyolysis |
4.7% |
| Blood Cholesterol Increased |
3.5% |
| Drug Ineffective |
3.5% |
| Muscular Weakness |
3.4% |
| Malaise |
3.4% |
| Vomiting |
2.9% |
| Rash |
2.7% |
| Cerebrovascular Accident |
2.5% |
| Liver Disorder |
2.4% |
| Nausea |
2.4% |
| Paraesthesia |
2.3% |
|
| Concomitant |
| Product Used For Unknown Indication |
28.5% |
| Drug Use For Unknown Indication |
14.6% |
| Hypertension |
10.9% |
| Blood Cholesterol Increased |
5.8% |
| Diabetes Mellitus |
5.4% |
| Rheumatoid Arthritis |
3.6% |
| Depression |
3.3% |
| Pain |
3.1% |
| Type 2 Diabetes Mellitus |
2.9% |
| Osteoporosis |
2.8% |
| Atrial Fibrillation |
2.4% |
| Gastrooesophageal Reflux Disease |
2.3% |
| Prophylaxis |
2.3% |
| Hyperlipidaemia |
2.1% |
| Cardiac Disorder |
2.0% |
| Blood Cholesterol |
1.7% |
| Chronic Obstructive Pulmonary Disease |
1.7% |
| Anxiety |
1.6% |
| Asthma |
1.5% |
| Smoking Cessation Therapy |
1.5% |
|
| Vomiting |
11.2% |
| Weight Decreased |
11.0% |
| Myocardial Infarction |
9.3% |
| Weight Increased |
7.9% |
| Drug Ineffective |
6.6% |
| Nausea |
6.3% |
| Flushing |
5.1% |
| Pain |
4.6% |
| Type 2 Diabetes Mellitus |
3.9% |
| Death |
3.7% |
| Pruritus |
3.5% |
| Rash |
3.4% |
| Urinary Tract Infection |
3.2% |
| Pneumonia |
3.1% |
| Tremor |
3.1% |
| Vision Blurred |
3.0% |
| Dyspnoea |
2.9% |
| Pain In Extremity |
2.8% |
| Somnolence |
2.8% |
| Renal Failure |
2.7% |
|
| Interacting |
| Product Used For Unknown Indication |
17.4% |
| Blood Cholesterol Increased |
10.7% |
| Diabetes Mellitus |
10.7% |
| Drug Use For Unknown Indication |
8.8% |
| Hypertension |
8.8% |
| Depression |
7.1% |
| Hypercholesterolaemia |
4.2% |
| Pain |
4.2% |
| Tachyarrhythmia |
3.4% |
| Gastrooesophageal Reflux Disease |
3.1% |
| Neuropathy Peripheral |
2.7% |
| Dyslipidaemia |
2.5% |
| Erectile Dysfunction |
2.5% |
| Prostatic Disorder |
2.3% |
| Blood Cholesterol |
2.1% |
| Arthritis Bacterial |
1.9% |
| Blood Cholesterol Abnormal |
1.9% |
| High Density Lipoprotein Decreased |
1.9% |
| Hyperlipidaemia |
1.9% |
| Idiopathic Thrombocytopenic Purpura |
1.7% |
|
| Drug Interaction |
19.8% |
| Rhabdomyolysis |
10.8% |
| Myocardial Infarction |
9.9% |
| Weight Increased |
9.0% |
| Weight Decreased |
6.3% |
| Hepatic Enzyme Increased |
4.5% |
| Myalgia |
4.5% |
| Vomiting |
4.5% |
| Arthralgia |
3.6% |
| Hallucination |
3.6% |
| Neuropathy Peripheral |
3.6% |
| Liver Function Test Abnormal |
2.7% |
| Renal Failure |
2.7% |
| Tremor |
2.7% |
| Urinary Retention |
2.7% |
| Amnesia |
1.8% |
| Arterial Thrombosis |
1.8% |
| Blood Glucose Decreased |
1.8% |
| Blood Triglycerides Increased |
1.8% |
| Drug Ineffective |
1.8% |
|
